Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced the sixth repurchase and cancellation of restricted A-shares under its incentive scheme. The company assures full responsibility for the accuracy of the announcement, emphasizing transparency and due diligence. This strategic move reflects the company’s ongoing commitment to optimizing its equity structure.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.